MedPath

The Application of Contrast-enhanced Ultrasound in Acute Kidney Injury in ICU

Not yet recruiting
Conditions
Intensive Care Unit
Acute Kidney Injury
Ultrasound
Interventions
Other: Renal microcirculation quantitatively assessed by Contrast-enhanced ultrasound
Registration Number
NCT06341062
Lead Sponsor
Peking University Third Hospital
Brief Summary

The goal of this study is to quantitatively assess renal microcirculation changes by contrast-enhanced ultrasound and to obtain systemic hemodynamic information by ultrasound Doppler at the same time, to analyze the relationship between renal microcirculation changes and systemic hemodynamic changes, and to explore its predictive value in renal function recovery in patients with critical acute kidney injury. The main questions it aims to answer are:

1. To explore the quantitative parameters of contrast-enhanced ultrasound which can reflect the changes of renal microcirculation.

2. To explore the relationship between renal microcirculation and systemic hemodynamics.

3. To explore the value of renal microflow changes quantitatively evaluated by contrast-enhanced ultrasound in predicting renal function recovery.

Detailed Description

Quantitative analysis of cortical perfusion by contrast-enhanced ultrasound; Echocardiography; Quantitative results of renal artery and vein spectrum

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
44
Inclusion Criteria
  • Age >18 years old;
  • AKI was diagnosed < 24 hours after first admission to intensive care unit (ICU) and the expected length of stay in ICU ≥48 hours;
  • Meet Kidney Disease Improving Global Outcomes (KDIGO) 2012 diagnostic criteria for acute kidney injury;
  • Contrast-enhanced ultrasound was performed within 24 hours after diagnosis of acute kidney injury (AKI).
Read More
Exclusion Criteria
  • Known severe chronic kidney disease (CKD≥ stage 4) or undergoing hemodialysis treatment;
  • Kidney transplantation or renal malignancy;
  • Terminal stage of malignant tumor;
  • Pregnancy;
  • Renal artery stenosis or renal vein thrombosis;
  • Allergy to contrast agent SonoVue(BraccoSpA, Milan, Italy) or its components, or the presence of severe cardiopulmonary insufficiency (e.g., right-to-left shunt heart disease or pulmonary systolic blood pressure >90mmHg).
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Patients not recovering before hospital dischargeRenal microcirculation quantitatively assessed by Contrast-enhanced ultrasoundNon-recovery is defined as no significant improvement or further increase in serum creatinine and/or urine volume, the need for dialysis, or death.
Primary Outcome Measures
NameTimeMethod
Serum creatinine values and/or urine outputThrough study completion, an average of 7 days

Complete recovery (defined as a return to normal serum creatinine and urine volume) and reversal of acute kidney injury (AKI) (more than 50% improvement in serum creatinine and/or urine volume from baseline), non-recovery included persistent AKI(no significant improvement or further increase in serum creatinine and/or urine volume, the need for dialysis, or death.)

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Department of Ultrasound Diagnosis, Peking University Third Hospital

🇨🇳

Beijing, Beijing, China

© Copyright 2025. All Rights Reserved by MedPath